. 2024 Jun 26;12(18):3395–3402. doi: 10.12998/wjcc.v12.i18.3395

Table 5.

Comparison of immune function indexes between the two groups, mean ± SD

Immune function indicators	Stage	Liver cancer resection group (n = 35)	Liver cancer ablation group (n = 35)	t	P value
CD4⁺ (%)	Before treatment	29.75 ± 6.32	29.52 ± 6.43	0.151	0.880
CD4⁺ (%)	After one month of treatment	35.27 ± 5.56^a	43.95 ± 5.72^a	6.437	< 0.001
CD8⁺ (%)	Before treatment	25.09 ± 4.78	25.43 ± 4.96	0.292	0.771
CD8⁺ (%)	After one month of treatment	22.75 ± 4.62^a	20.38 ± 3.91^a	2.317	0.024
CD4⁺/CD8⁺	Before treatment	1.19 ± 0.28	1.16 ± 0.25	0.473	0.638
CD4⁺/CD8⁺	After one month of treatment	1.55 ± 0.32^a	2.16 ± 0.39^a	7.154	< 0.001

P < 0.05 vs before treatment.